OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
Yan Cui, Ying Ying, Andrew van Hasselt et al. · 2008
Read OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation by Yan Cui, Ying Ying, Andrew van Hasselt et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002990.txt.
Description
Yan Cui, Ying Ying, Andrew van Hasselt and co-authors studied the tumor suppressor OPCML in 2008. Finding suppressor genes silenced by methylation helps reveal how tumors form and can yield biomarkers. Loss of DNA at chromosome region 11q25 is common in many tumors, including nasopharyngeal carcinoma.
OPCML sits in that region. The team reports it as a broad tumor suppressor across multiple carcinomas and lymphomas, frequently switched off by epigenetic means rather than mutation. Published in PLOS ONE, broad action across cancer types makes the gene notable for both biology and testing. The full text gives methods, results, and references for readers who want to check each step.
Catalog record
| CREATOR | Yan Cui, Ying Ying, Andrew van Hasselt et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002990